Principles and practice of the biologic therapy of cancer:
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
Philadelphia [u.a.]
Lippincott Williams & Wilkins
2000
|
| Ausgabe: | 3. ed. |
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | XVII, 916 S. Ill., graph. Darst. |
| ISBN: | 0781722721 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV013351997 | ||
| 003 | DE-604 | ||
| 005 | 20011129 | ||
| 007 | t | ||
| 008 | 000920s2000 ad|| |||| 00||| eng d | ||
| 020 | |a 0781722721 |9 0-7817-2272-1 | ||
| 035 | |a (OCoLC)44603547 | ||
| 035 | |a (DE-599)BVBBV013351997 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-29 |a DE-91 |a DE-578 | ||
| 050 | 0 | |a RC271.G45 | |
| 082 | 0 | |a 616.99406 |2 21 | |
| 084 | |a XH 3500 |0 (DE-625)152892:12905 |2 rvk | ||
| 084 | |a QZ 266 |2 nlm | ||
| 245 | 1 | 0 | |a Principles and practice of the biologic therapy of cancer |c ed. by Steven A. Rosenberg |
| 250 | |a 3. ed. | ||
| 264 | 1 | |a Philadelphia [u.a.] |b Lippincott Williams & Wilkins |c 2000 | |
| 300 | |a XVII, 916 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 650 | 4 | |a Cancer - Immunothérapie | |
| 650 | 4 | |a Cancer - Thérapie génique | |
| 650 | 7 | |a Immunobiologie |2 gtt | |
| 650 | 4 | |a Immunomodulateurs - Emploi en thérapeutique | |
| 650 | 7 | |a Kanker |2 gtt | |
| 650 | 7 | |a Therapieën |2 gtt | |
| 650 | 4 | |a Biological response modifiers |x Therapeutic use | |
| 650 | 4 | |a Cancer |x Gene therapy | |
| 650 | 4 | |a Cancer |x Immunotherapy | |
| 650 | 4 | |a Immunologic Factors |x immunology | |
| 650 | 4 | |a Immunologic Factors |x therapeutic use | |
| 650 | 4 | |a Immunotherapy | |
| 650 | 4 | |a Neoplasms |x therapy | |
| 650 | 0 | 7 | |a Immuntherapie |0 (DE-588)4026640-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Biological response modifier |0 (DE-588)4475179-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Therapie |0 (DE-588)4059798-2 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |2 gnd |9 rswk-swf |
| 689 | 0 | 0 | |a Biological response modifier |0 (DE-588)4475179-5 |D s |
| 689 | 0 | 1 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 0 | 2 | |a Therapie |0 (DE-588)4059798-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a Krebs |g Medizin |0 (DE-588)4073781-0 |D s |
| 689 | 1 | 1 | |a Immuntherapie |0 (DE-588)4026640-0 |D s |
| 689 | 1 | |5 DE-604 | |
| 700 | 1 | |a Rosenberg, Steven A. |e Sonstige |4 oth | |
| 856 | 4 | 2 | |m HBZ Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009106239&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-009106239 | ||
Datensatz im Suchindex
| _version_ | 1804128127946850304 |
|---|---|
| adam_text | Contributing Authors ix
Preface xvii
SECTION I: PRINCIPLES AND PRACTICE
OF CYTOKINE THERAPY 1
1. Interleukins: Overview 3
Scott K. Durum
2. Interleukin 2: Preclinical Trials 19
| Richard]. Barth, Jr., and James J. Mutt
I 3. Interleukin 2: Clinical Applications 32
3.1 Principles of Administration and Management
of Side Effects 32
Douglas]. Schwartzentruber
3.2 Melanoma 50
MichaelB. Atkins, Arun Shet, and Jeffrey A. Sosman
3.3 Renal Cell Carcinoma 73
James Chung Yin Yang
3.4 Hematologic Malignancies 83
Alexander Fefer
4. Interleukin 4: Clinical Applications 93
Hideho Okada and Michael T. Lotze
5. Interleukin 12: Clinical Applications 103
Hideaki Tahara and Michael T. Lotze
6. Colony Stimulating Factors: Basic Principles
and Preclinical Studies 113
Malcolm A. S. Moore
7. Colony Stimulating Factors: Clinical Applications 141
7.1 Colony Stimulating Factors in Oncology 141
John A. Glaspy
7.2 Platelet Stimulating Factors 152
Kenneth Kaushansky
7.3 Erythropoietin Therapy for the
Cancer Patient 163
John A. Glaspy
8. Tumor Necrosis Factor: Basic Principles
and Clinical Applications in Systemic
and Regional Cancer Treatment 174
H. Richard Alexander, Jr., and Andrew L. Feldman
9. Interferon OC and |3: Basic Principles
and Preclinical Studies 194
Bryan R. G. Williams
10. Interferon a and p: Clinical Applications 209
10.1 Leukemias, Lymphoma, and
Multiple Myeloma 209
Moshe Talpaz, Farhad Ravandi, Razelle Kurzrock,
Zeev Estrov, and Hagop M. Kantarjian
10.2 Melanoma 224
John M. Kirkwood
10.3 Renal Cell Cancer 252
Christopher Tretter, PaulD. Savage, Hyman B. Muss,
and Marc S. Ernstoff
10.4 Kaposi s Sarcoma 265
Susan E. Krown
10.5 Epithelial Cancers 275
Sanjiv S. Agarwala
11. Interferon y: Basic Principles
and Clinical Applications 286
Vijay Shankaran and Robert D. Schreiber
SECTION II: PRINCIPLES AND PRACTICE
OF CELL TRANSFER THERAPY 303
12. Cell Transfer Therapy: Basic Principles
and Preclinical Studies 305
Mark E. Dudley
13. Cell Transfer Therapy: Clinical Applications 322
13.1 Melanoma 322
Steven A. Rosenberg
13.2 Renal Cell Carcinoma 333
ArieS. Belldegrun, Robert A. Figlin, and Belur Patel
v
vi Contents
13.3 AllogeneicGraft Versus Leukemia
and Antitumor Effects 346
John Barrett
13.4 Adoptive Cellular Immunotherapy for Epstein
Barr Virus Associated Malignancies 357
Malcolm K. Brenner, Helen E. Heslop,
and Cliona M. Rooney
SECTION III: PRINCIPLES AND PRACTICE
OF MONOCLONAL ANTIBODY THERAPY 369
14. Monoclonal Antibodies: Basic Principles 371
14.1 Basic Concepts and Antigens Recognized 371
Kenneth A. Foon
14.2 Immunotoxins and Recombinant
Immunotoxins 382
Lee H. Pai Scherf, Robert J. Kreitman, and Ira Pastan
14.3 Radioisotope Conjugates 396
Steven M. Larson, Chaitanya Divgi, George Sgouros,
Nat Kong V. Cheung, and David A, Scheinberg
15. Monoclonal Antibodies: Clinical Applications 413
15.1 B Cell Lymphomas 413
Scott M. Schuetze and David G. Maloney
15.2 T Cell Leukemia and Lymphoma 428
Thomas A. Waldmann
15.3 Melanoma 439
Paul B. Chapman and Alan N. Houghton
15.4 Breast Cancer and Other Adenocarcinomas 452
Margaret von Mehren and Louis M. Weiner
15.5 Monoclonal Antibodies Directed Against
Growth Factor Receptors 475
Jose Baselga and John Mendelsohn
SECTION IV: PRINCIPLES AND PRACTICE
OF CANCER VACCINES 491
16. Cancer Vaccines: Cancer Antigens 493
16.1 Shared Tumor Specific Antigens 493
Thierry Boon andBenoitJ. Van den Eynde
16.2 Differentiation Antigens 504
PaulERobbins
16.3 Viral Antigens 514
Sjoerd H. van der Burg, Rienk Offringa, and
Cornells J. M. Melief
16.4 Oncogenes and Mutations 526
Jay A. Berzofiky, LeeJ. Helman, and
David P. Carbone
16.5 Carbohydrate Antigens on Glycolipids
and Glycoproteins 541
Philip O. Livingston and Kenneth O. Lloyd
16.6 Glycoprotein Antigens 549
OliveraJ. Finn
16.7 Identification of Human Tumor Antigens by
Serological Expression Cloning 557
Yao Tseng Chen, Matthew]. Scanlan, Yuichi Obata,
and Lloyd J. Old
17. Cancer Vaccines: Basic Principles 571
17.1 General Concepts and Predinical Studies 571
Nicholas P. Restifo
17.2 Immune Adjuvants 584
Michael L. Salgaller
17.3 Mechanisms of Immune Escape and Immune
Tolerance 601
Francesco M. Marincola
17.4 Principles of Immune Monitoring in Cancer
Vaccine Trials 617
Mario Sznol and Francesco M. Marincola
18. Cancer Vaccines: Clinical Applications 632
18.1 Whole Cell and Lysate Vaccines 632
Muthukumaran Sivanandham,
Christos L. Stavropoulos, and Marc K. Wallack
18.2 Genetically Modified Tumor Vaccines 647
Drew M. Pardoll and Elizabeth M. Jaffee
18.3 Peptides and Protein Vaccines 662
Steven A. Rosenberg
18.4 DNA Vaccines 674
Stephen A. White and Robert M. Conry
18.5 Recombinant Poxvirus Vaccines 686
Jeffrey Schlom and Dennis Panicali
18.6 Adenovirus and Other Viral Vaccines 694
Bruce Roberts
18.7 Dendritic Cell Vaccines 705
Ramsey M. Dallal, Robbie Mailliard,
and Michael T. Lotze
18.8 Vaccines Against Carbohydrate Antigens
on Glycolipids and Glycoproteins 721
Philip O. Livingston and Govindaswami Ragupathi
SECTION V: PRINCIPLES AND PRACTICE
OF GENE THERAPY 731
19. Basic Principles of Gene Therapy 733
19.1 Basic Principles and Safety Considerations 733
Kenneth G. Cornetta and Michael J. Robertson
19.2 Gene Transfer into Mammalian Cells 747
Susan A. Zullo, Natasha J. Caplen,
and Richard A. Morgan
20. Gene Therapy: Clinical Applications 757
20.1 Gene Therapy Using Lymphocyte
Modification 757
Patrick Hwu
20.2 Gene Therapy Using Stem
Cell Modification 769
Albert Deisseroth, Jo Hong Won, Lixin Zhang,
Xue Yuen Peng, Takuma Fujii, Tao Wang,
X. Y. David Guo, Allon Canaan, S. Shrimdkandada,
Frank Hsieh, and Andres Canova
20.3 Suicide Gene Therapy 781
David L. Bartlett and J. Andrea McCart
20.4 Gene Therapy Using Direct In Vivo
Gene Injection 796
Bingliang Fang and Jack A. Roth
20.5 Antisense Oligodeoxynucleotides 811
Irina Lebedeva and C. A. Stein
SECTION VI: PRINCIPLES AND PRACTICE
OF ANTIANGIOGENIC THERAPY 825
21. Antiangiogenesis: Basic Principles
and Preclinical Models 827
MichaelS. O Reilly
22. Antiangiogenesis: Clinical Applications 844
Steven K. Libutti and James M. Pluda
Contents
SECTION VII: EVOLVING APPROACHES
TO BIOLOGIC THERAPY 863
23. Delivery of Biologic Molecules and Cells
to Tumors 865
RakeshKJain
24. Flt 3 and Flt 3 Ligand 875
Eugene Maraskovsky, Stewart D. Lyman,
Charles R. Maliszewski, and David H. Lynch
25. CTLA 4 Blockade in Tumor Immunotherapy 890
James P. Allison, Arthur A. Hurwitz, Andrea van Elsas,
Eugene Kwon, Timothy Sullivan, Barbara Foster,
and Norman Greenberg
Index 897
|
| any_adam_object | 1 |
| building | Verbundindex |
| bvnumber | BV013351997 |
| callnumber-first | R - Medicine |
| callnumber-label | RC271 |
| callnumber-raw | RC271.G45 |
| callnumber-search | RC271.G45 |
| callnumber-sort | RC 3271 G45 |
| callnumber-subject | RC - Internal Medicine |
| classification_rvk | XH 3500 |
| ctrlnum | (OCoLC)44603547 (DE-599)BVBBV013351997 |
| dewey-full | 616.99406 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.99406 |
| dewey-search | 616.99406 |
| dewey-sort | 3616.99406 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| edition | 3. ed. |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02334nam a2200613 c 4500</leader><controlfield tag="001">BV013351997</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20011129 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">000920s2000 ad|| |||| 00||| eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0781722721</subfield><subfield code="9">0-7817-2272-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)44603547</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV013351997</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-29</subfield><subfield code="a">DE-91</subfield><subfield code="a">DE-578</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">RC271.G45</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.99406</subfield><subfield code="2">21</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XH 3500</subfield><subfield code="0">(DE-625)152892:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QZ 266</subfield><subfield code="2">nlm</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Principles and practice of the biologic therapy of cancer</subfield><subfield code="c">ed. by Steven A. Rosenberg</subfield></datafield><datafield tag="250" ind1=" " ind2=" "><subfield code="a">3. ed.</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Philadelphia [u.a.]</subfield><subfield code="b">Lippincott Williams & Wilkins</subfield><subfield code="c">2000</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVII, 916 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer - Immunothérapie</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer - Thérapie génique</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Immunobiologie</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunomodulateurs - Emploi en thérapeutique</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Kanker</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Therapieën</subfield><subfield code="2">gtt</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Biological response modifiers</subfield><subfield code="x">Therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Gene therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Immunotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunologic Factors</subfield><subfield code="x">immunology</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunologic Factors</subfield><subfield code="x">therapeutic use</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Immunotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Biological response modifier</subfield><subfield code="0">(DE-588)4475179-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Biological response modifier</subfield><subfield code="0">(DE-588)4475179-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Therapie</subfield><subfield code="0">(DE-588)4059798-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Krebs</subfield><subfield code="g">Medizin</subfield><subfield code="0">(DE-588)4073781-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Immuntherapie</subfield><subfield code="0">(DE-588)4026640-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Rosenberg, Steven A.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">HBZ Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009106239&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-009106239</subfield></datafield></record></collection> |
| id | DE-604.BV013351997 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T18:44:19Z |
| institution | BVB |
| isbn | 0781722721 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-009106239 |
| oclc_num | 44603547 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-29 DE-91 DE-BY-TUM DE-578 |
| owner_facet | DE-355 DE-BY-UBR DE-29 DE-91 DE-BY-TUM DE-578 |
| physical | XVII, 916 S. Ill., graph. Darst. |
| publishDate | 2000 |
| publishDateSearch | 2000 |
| publishDateSort | 2000 |
| publisher | Lippincott Williams & Wilkins |
| record_format | marc |
| spelling | Principles and practice of the biologic therapy of cancer ed. by Steven A. Rosenberg 3. ed. Philadelphia [u.a.] Lippincott Williams & Wilkins 2000 XVII, 916 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Cancer - Immunothérapie Cancer - Thérapie génique Immunobiologie gtt Immunomodulateurs - Emploi en thérapeutique Kanker gtt Therapieën gtt Biological response modifiers Therapeutic use Cancer Gene therapy Cancer Immunotherapy Immunologic Factors immunology Immunologic Factors therapeutic use Immunotherapy Neoplasms therapy Immuntherapie (DE-588)4026640-0 gnd rswk-swf Biological response modifier (DE-588)4475179-5 gnd rswk-swf Therapie (DE-588)4059798-2 gnd rswk-swf Krebs Medizin (DE-588)4073781-0 gnd rswk-swf Biological response modifier (DE-588)4475179-5 s Krebs Medizin (DE-588)4073781-0 s Therapie (DE-588)4059798-2 s DE-604 Immuntherapie (DE-588)4026640-0 s Rosenberg, Steven A. Sonstige oth HBZ Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009106239&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Principles and practice of the biologic therapy of cancer Cancer - Immunothérapie Cancer - Thérapie génique Immunobiologie gtt Immunomodulateurs - Emploi en thérapeutique Kanker gtt Therapieën gtt Biological response modifiers Therapeutic use Cancer Gene therapy Cancer Immunotherapy Immunologic Factors immunology Immunologic Factors therapeutic use Immunotherapy Neoplasms therapy Immuntherapie (DE-588)4026640-0 gnd Biological response modifier (DE-588)4475179-5 gnd Therapie (DE-588)4059798-2 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| subject_GND | (DE-588)4026640-0 (DE-588)4475179-5 (DE-588)4059798-2 (DE-588)4073781-0 |
| title | Principles and practice of the biologic therapy of cancer |
| title_auth | Principles and practice of the biologic therapy of cancer |
| title_exact_search | Principles and practice of the biologic therapy of cancer |
| title_full | Principles and practice of the biologic therapy of cancer ed. by Steven A. Rosenberg |
| title_fullStr | Principles and practice of the biologic therapy of cancer ed. by Steven A. Rosenberg |
| title_full_unstemmed | Principles and practice of the biologic therapy of cancer ed. by Steven A. Rosenberg |
| title_short | Principles and practice of the biologic therapy of cancer |
| title_sort | principles and practice of the biologic therapy of cancer |
| topic | Cancer - Immunothérapie Cancer - Thérapie génique Immunobiologie gtt Immunomodulateurs - Emploi en thérapeutique Kanker gtt Therapieën gtt Biological response modifiers Therapeutic use Cancer Gene therapy Cancer Immunotherapy Immunologic Factors immunology Immunologic Factors therapeutic use Immunotherapy Neoplasms therapy Immuntherapie (DE-588)4026640-0 gnd Biological response modifier (DE-588)4475179-5 gnd Therapie (DE-588)4059798-2 gnd Krebs Medizin (DE-588)4073781-0 gnd |
| topic_facet | Cancer - Immunothérapie Cancer - Thérapie génique Immunobiologie Immunomodulateurs - Emploi en thérapeutique Kanker Therapieën Biological response modifiers Therapeutic use Cancer Gene therapy Cancer Immunotherapy Immunologic Factors immunology Immunologic Factors therapeutic use Immunotherapy Neoplasms therapy Immuntherapie Biological response modifier Therapie Krebs Medizin |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=009106239&sequence=000002&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT rosenbergstevena principlesandpracticeofthebiologictherapyofcancer |